Revenue | ₹2,430.34Cr |
Net Profits | ₹326.27Cr |
Net Profit Margins | 13.42% |
Ipca Laboratories Ltd’s revenue jumped 7.28% since last year same period to ₹2,430.34Cr in the Q3 2025-2026. On a quarterly growth basis, Ipca Laboratories Ltd has generated -5.96% fall in its revenue since last 3-months.
Ipca Laboratories Ltd’s net profit jumped 31.49% since last year same period to ₹326.27Cr in the Q3 2025-2026. On a quarterly growth basis, Ipca Laboratories Ltd has generated 15.47% jump in its net profits since last 3-months.
Ipca Laboratories Ltd’s net profit margin jumped 22.57% since last year same period to 13.42% in the Q3 2025-2026. On a quarterly growth basis, Ipca Laboratories Ltd has generated 22.78% jumped in its net profit margins since last 3-months.
The revenue for Ipca Laboratories Ltd in the Q3 results 2025 was ₹2,430.34Cr.
The net profit for Ipca Laboratories Ltd in the Q3 results 2025 was ₹326.27Cr.
The net profit margin for Ipca Laboratories Ltd in the Q3 results 2025 was 13.42%.
The revenue for Ipca Laboratories Ltd in the Q3 results 2024 was ₹2,265.48Cr.
The net profit for Ipca Laboratories Ltd in the Q3 results 2024 was ₹248.14Cr.
The net profit margin for Ipca Laboratories Ltd in the Q3 results 2024 was 10.95%.